• Something wrong with this record ?

Vaccination against tick-borne encephalitis elicits a detectable NS1 IgG antibody response

R. Ackermann-Gäumann, A. Brêchet, J. Smetana, J. Salát, R. Lienhard, A. Croxatto, P. Polcarová, R. Chlíbek, D. Růžek

. 2023 ; 322 (-) : 114831. [pub] 20231013

Language English Country Netherlands

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc24000420

Vaccine-induced protection against tick-borne encephalitis virus (TBEV) is mediated by antibodies to the viral particle/envelope protein. The detection of non-structural protein 1 (NS1) specific antibodies has been suggested as a marker indicative of natural infections. However, recent work has shown that TBEV vaccines contain traces of NS1, and immunization of mice induced low amounts of NS1-specific antibodies. In this study, we investigated if vaccination induces TBEV NS1-specific antibodies in humans. Healthy army members (n = 898) were asked to fill in a questionnaire relating to flavivirus vaccination or infection, and blood samples were collected. In addition, samples of 71 suspected acute TBE cases were included. All samples were screened for the presence of TBEV NS1-specific IgG antibodies using an in-house developed ELISA. Antibodies were quantified as percent positivity in reference to a positive control. For qualitative evaluation, cut-off for positivity was defined based on the mean OD of the lower 95% of the vaccinated individuals + 3 SD. We found significantly higher NS1-specific IgG antibody titers (i.e., quantitative evaluation) in individuals having received 2, 3, or 4 or more vaccine doses than in non-vaccinated individuals. Similarly, the percentage of individuals with a positive test result (i.e., qualitative evaluation) was higher in individuals vaccinated against tick-borne encephalitis than in unvaccinated study participants. Although NS1-specific IgG titers remained at a relatively low level when compared to TBE patients, a clear distinction was not always possible. Establishing a clear cut-off point in detection systems is critical for NS1-specific antibodies to serve as a marker for distinguishing the immune response after vaccination and infection.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24000420
003      
CZ-PrNML
005      
20240306124349.0
007      
ta
008      
240109e20231013ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jviromet.2023.114831 $2 doi
035    __
$a (PubMed)37838083
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Ackermann-Gäumann, Rahel $u Microbiologie, ADMED Analyses et Diagnostics Médicaux, La Chaux-de-Fonds, Switzerland; Swiss National Reference Center for Tick-Transmitted Diseases, Switzerland. Electronic address: rahel.ackermann@ne.ch
245    10
$a Vaccination against tick-borne encephalitis elicits a detectable NS1 IgG antibody response / $c R. Ackermann-Gäumann, A. Brêchet, J. Smetana, J. Salát, R. Lienhard, A. Croxatto, P. Polcarová, R. Chlíbek, D. Růžek
520    9_
$a Vaccine-induced protection against tick-borne encephalitis virus (TBEV) is mediated by antibodies to the viral particle/envelope protein. The detection of non-structural protein 1 (NS1) specific antibodies has been suggested as a marker indicative of natural infections. However, recent work has shown that TBEV vaccines contain traces of NS1, and immunization of mice induced low amounts of NS1-specific antibodies. In this study, we investigated if vaccination induces TBEV NS1-specific antibodies in humans. Healthy army members (n = 898) were asked to fill in a questionnaire relating to flavivirus vaccination or infection, and blood samples were collected. In addition, samples of 71 suspected acute TBE cases were included. All samples were screened for the presence of TBEV NS1-specific IgG antibodies using an in-house developed ELISA. Antibodies were quantified as percent positivity in reference to a positive control. For qualitative evaluation, cut-off for positivity was defined based on the mean OD of the lower 95% of the vaccinated individuals + 3 SD. We found significantly higher NS1-specific IgG antibody titers (i.e., quantitative evaluation) in individuals having received 2, 3, or 4 or more vaccine doses than in non-vaccinated individuals. Similarly, the percentage of individuals with a positive test result (i.e., qualitative evaluation) was higher in individuals vaccinated against tick-borne encephalitis than in unvaccinated study participants. Although NS1-specific IgG titers remained at a relatively low level when compared to TBE patients, a clear distinction was not always possible. Establishing a clear cut-off point in detection systems is critical for NS1-specific antibodies to serve as a marker for distinguishing the immune response after vaccination and infection.
650    _2
$a lidé $7 D006801
650    _2
$a protilátky virové $7 D000914
650    _2
$a tvorba protilátek $7 D000917
650    12
$a viry klíšťové encefalitidy $7 D004669
650    12
$a klíšťová encefalitida $x prevence a kontrola $7 D004675
650    12
$a infekce viry z rodu Flavivirus $7 D018177
650    _2
$a imunoglobulin G $7 D007074
650    _2
$a vakcinace $7 D014611
650    12
$a virové vakcíny $7 D014765
655    _2
$a časopisecké články $7 D016428
700    1_
$a Brêchet, Arthur $u Microbiologie, ADMED Analyses et Diagnostics Médicaux, La Chaux-de-Fonds, Switzerland
700    1_
$a Smetana, Jan $u Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic
700    1_
$a Salát, Jiři $u Laboratory of Emerging Viral Infections, Veterinary Research Institute, Brno, Czech Republic; Laboratory of Arbovirology, Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, Ceske Budejovice, Czech Republic; Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic
700    1_
$a Lienhard, Reto $u Microbiologie, ADMED Analyses et Diagnostics Médicaux, La Chaux-de-Fonds, Switzerland; Swiss National Reference Center for Tick-Transmitted Diseases, Switzerland
700    1_
$a Croxatto, Antony $u Microbiologie, ADMED Analyses et Diagnostics Médicaux, La Chaux-de-Fonds, Switzerland; Swiss National Reference Center for Tick-Transmitted Diseases, Switzerland
700    1_
$a Polcarová, Petra $u Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic
700    1_
$a Chlíbek, Roman $u Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic
700    1_
$a Růžek, Daniel, $d 1981- $u Laboratory of Emerging Viral Infections, Veterinary Research Institute, Brno, Czech Republic; Laboratory of Arbovirology, Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, Ceske Budejovice, Czech Republic; Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic $7 stk2008441707
773    0_
$w MED00003047 $t Journal of virological methods $x 1879-0984 $g Roč. 322 (20231013), s. 114831
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37838083 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240109 $b ABA008
991    __
$a 20240306124344 $b ABA008
999    __
$a ok $b bmc $g 2049216 $s 1210114
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 322 $c - $d 114831 $e 20231013 $i 1879-0984 $m Journal of virological methods $n J Virol Methods $x MED00003047
LZP    __
$a Pubmed-20240109

Find record

Citation metrics

Archiving options